中交(01800.HK)旗下公司計劃發行15億美元次級擔保永續證券
中國交通建設(01800.HK)公布,公司間接持股98.98%的CCCI Treasure作為發行人與公司及瑞士信貸、匯豐、交銀國際、中信里昂證券、華泰金控、SMBCNikko及渣打銀行訂立認購協議,內容有關發行及購買總本金額分別為10億美元及5億美元的A系列證券及B系列次級擔保永續證券。
A系列證券的初始票息將為每年3.425%,而B系列證券的初始票息將為每年3.65%。A系列證券的票息將首先於2025年2月21日重置,其後每五年重置一次。根據B系列證券的條款及條件,B系列證券的票息將首先於2027年2月21日重置,其後每五年重置一次。
發行人有意將證券發售的所得款項用於現有債務再融資和一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.